Dosage [qnco]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Inflammatory [ftcn]
Marker [clna]
Endothelial [tisu]
function [phsf]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
Oral [spco]
Estrogen Replacement Therapy [topp]
postmenopausal [tmco]
Women [popg]
Endothelial [tisu]
function [phsf]
Plasma C-reactive protein [aapp]
Interleukin-6 [aapp, imft]
Concentration [menp]
Oral [spco]
Estrogen Replacement Therapy [topp]
Increased [qnco]
coronary heart disease [dsyn]
treatment [ftcn]
Observational Study [resa]
Low dose [qnco]
Oral [spco]
Estrogen [horm, phsu, strd]
coronary heart disease [dsyn]
Purpose [ftcn]
Present [qnco]
Study [mnob]
investigate [ftcn]
effects [qlco]
low estrogen [fndg]
Dose [qnco]
Oral [spco]
vascular [bpoc]
Inflammatory [ftcn]
Marker [clna]
Endothelium [tisu]
Dependent [qlco]
Vasodilation [phsf]
postmenopausal [tmco]
Women [popg]
Methods [inpr]
postmenopausal [tmco]
Women [popg]
randomized [resa]
Group [idcn]
Receive [qlco]
treatment [ftcn]
N NOS [aapp, imft]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Dosage [qnco]
mg% [qnco]
N NOS [aapp, imft]
mg% [qnco]
N NOS [aapp, imft]
Daily [tmco]
3 Months [tmco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Dosage [qnco]
mg% [qnco]
increases [ftcn]
plasma concentration [qnco]
C-reactive protein [aapp, imft]
Serum Amyloid A [aapp, imft]
Interleukin-6 [aapp, imft]
pg/mL [qnco]
Contrast [qlco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Dosage [qnco]
mg% [qnco]
Inflammatory [ftcn]
Marker [clna]
Dosages [qnco]
Estrogen [horm, phsu, strd]
Decreased [qnco]
Selectin [aapp, bacs]
Concentration [menp]
Concentrations [menp]
Vascular Cell Adhesion Molecule [aapp, imft]
Unchanged [fndg]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Group [idcn]
Flow [npop]
mediated [socb]
Vasodilation [phsf]
Brachial Artery [bpoc]
Increased [qnco]
Nitroglycerin [orch, phsu]
Induced [ftcn]
Vasodilation [phsf]
Unaltered [qlco]
Conclusions [idcn]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Low dose [qnco]
mg% [qnco]
postmenopausal [tmco]
Women [popg]
Eliminated [qlco]
adverse effects [ftcn]
Dosage [qnco]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
vascular [bpoc]
Inflammatory [ftcn]
Marker [clna]
Preserving [ftcn]
Favorable [qlco]
effects [qlco]
Estrogen [horm, phsu, strd]
Cell Adhesion Molecules [aapp, bacs]
Endothelial [tisu]
function [phsf]
